Tiotropium add-on therapy in adolescents with moderate asthma: A 1-year randomized controlled trial

2016140 citationsJournal Articlehybrid Open Access

Authors

Eckard Hamelmann · Evangelisches Krankenhaus Bielefeld

Eric D. Bateman · University of Cape Town

Christian Vogelberg · University Hospital Carl Gustav Carus

Stanley J. Szefler · University of Colorado Denver

Mark Vandewalker · University of the Ozarks

Petra Moroni-Zentgraf · Boehringer Ingelheim (Germany)

Mandy Avis

Abstract

Once-daily tiotropium significantly improved lung function and was safe and well tolerated when added to at least ICS maintenance therapy in adolescent patients with moderate symptomatic asthma. Larger responses were observed with the 5-μg tiotropium dose.

Topics & Keywords

Asthma and respiratory diseases Respiratory and Cough-Related Research Inhalation and Respiratory Drug Delivery

Publication Details

Published in: Journal of Allergy and Clinical Immunology

Volume 138, Issue 2, pp. 441-450.e8

DOI: 10.1016/j.jaci.2016.01.011

Field-Weighted Citation Impact: 17.83

Command Palette

Tiotropium add-on therapy in adolescents with moderate asthma: A 1-year randomized controlled trial

Authors

Abstract

Topics & Keywords

Publication Details